Spinal Muscular Atrophy (SMA) is a rare and serious neuromuscular disease that affects the nerve cells in the spinal cord, leading to progressive loss of muscle function. SMA is a genetic condition, i.e. it is caused by mutations in specific genes that play a critical role in the survival of the motor cells that control the muscles. In this article, we’ll explore in detail what SMA is, how it manifests itself, the possibilities for treatment and cure, as well as the importance of early detection through genetic testing, including ConectGene’s BabyVip – Cheek Test, which analyzes 340 genetic diseases, including SMA.
The Concept of Spinal Muscular Atrophy
Spinal Muscular Atrophy is an inherited genetic disease characterized by the progressive degeneration of motor cells in the spinal cord and brainstem. These motor cells play a key role in transmitting nerve impulses from the neurons to the muscles, enabling movement. When these motor cells are affected, the muscles lose their ability to contract and function normally, leading to muscle weakness, paralysis and, in severe cases, difficulty breathing.
How SMA manifests itself
SMA is a heterogeneous condition, which means that its severity and age of onset can vary widely from person to person. It is generally classified into different types based on the severity of the symptoms and the age of onset:
- SMA Type 1 (SMA1): This is the most severe form and usually manifests itself in the first few months of life. Babies with SMA1 often have extreme muscle weakness and difficulty breathing, which can be lethal if not treated early.
- SMA Type 2 (SMA2): Usually manifests in early childhood. Children with SMA2 have significant muscle weakness, but generally don’t face the same respiratory challenges as children with SMA1.
- SMA Type 3 (SMA3): Begins in childhood or adolescence and is less severe than types 1 and 2. Symptoms range from mild to moderate, and people with SMA3 can have a normal life expectancy.
- SMA Type 4 (SMA4): This is the mildest form of SMA and usually manifests in adulthood. Symptoms are less severe and life expectancy is normal.
The main common feature between the types of SMA is the progressive loss of muscle function, which affects quality of life and, in many cases, can be fatal if left untreated.
Possible Cure and Treatments for SMA
Until recently, SMA was a disease with few effective treatment options. However, in recent years, significant advances have been made in the field of gene therapy, providing hope for SMA patients. One of the most notable treatments is the drug Spinraza (nusinersen), approved by the FDA in 2016 and already covered by SUS. Spinraza is administered by injection into the spine and works by modifying gene expression, increasing the production of the SMN (Survival Motor Neuron) protein, which is deficient in people with SMA. This treatment can slow down the progression of the disease and improve quality of life.
Another revolutionary treatment is Zolgensma therapy, a gene therapy approved in 2019 that aims to replace the defective gene responsible for SMA with a functional gene. This approach is a real hope for a definitive cure for SMA, especially when administered at very early stages of life.
The Importance of Early Detection through Genetic Testing
Detecting SMA as early as possible is fundamental to successful treatment. Genetic testing plays a crucial role in identifying SMA in newborns and at-risk individuals. ConectGene’s BabyVip – Cheek Test genetic test is an innovative tool that analyzes 340 genetic diseases, including Spinal Cord Atrophy. This test can be carried out shortly after birth by taking a sample of cells from the baby’s cheek, making the process painless and safe.
Early detection of SMA through genetic testing allows doctors to start treatment as early as possible, increasing the chances of success and improving the patient’s quality of life. Early detection is also essential for parents to receive genetic counseling and information about the risk of transmitting the disease to future children.
Newborn Genetic Screening: A Step towards Prevention
In addition to the early detection of SMA, neonatal genetic screening plays a vital role in identifying other treatable diseases that can affect newborns. This screening involves analyzing a sample of the baby’s blood to identify genetic mutations associated with various medical conditions.
Newborn genetic screening allows for the early diagnosis of hereditary diseases such as phenylketonuria, cystic fibrosis, congenital hypothyroidism, retinoblastoma, among others. Early detection of these conditions makes it possible to start treatment and medical interventions immediately, often avoiding serious complications and improving the quality of life of affected babies.
The BabyVip – ConectGene Cheek Test: A Powerful Tool
ConectGene’s BabyVip Cheek Test is a powerful tool that offers a comprehensive analysis of 340 genetic diseases, including Spinal Cord Atrophy. This test is safe, non-invasive and painless, making it an affordable option for families who want to ensure their child’s well-being from birth.
Through neonatal genetic screening and the use of genetic tests such as BabyVip, families can take preventative measures and be prepared to face any health challenges their children may face. Early detection not only allows for effective treatments, but also gives parents peace of mind, helping to create a healthy and safe environment for their children’s growth and development.
In summary, Spinal Muscular Atrophy is a devastating genetic condition that affects the quality of life and, in some cases, the survival of patients. However, with advances in gene therapy and early detection through genetic testing, there is hope for those facing SMA. Newborn genetic screening, including ConectGene’s BabyVip Cheek Test, plays a key role in identifying treatable diseases and preventing serious complications. It is essential that awareness of these tools and the importance of early detection spreads, so that all children have the opportunity to grow up healthy and happy.
As informações contidas neste site são fornecidas apenas como divulgação de informações gerais e não substituem o aconselhamento médico profissional, o diagnóstico ou o tratamento de um profissional de saúde qualificado. Sempre procure o conselho de seu médico ou profissional de saúde quando tiver dúvida sobre ingestão de medicamente ou condição de saúde.
